Oyster Point Pharma, Inc. Financing Cash Flow
Oyster Point Pharma, Inc. reported Financing Cash Flow of $76.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-11-10
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was -$166.00K, a 100.41% decline year-over-year.
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $460.00K, a 342.31% increase year-over-year.
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was -$218.00K, a 211.79% decline year-over-year.
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $50.93M.
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $91.64M, a 18.57% decline from fiscal 2020.
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $112.55M, a 35.68% decline from fiscal 2019.
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $174.99M.
- Oyster Point Pharma, Inc. net cash provided by (used in) financing activities for fiscal 2018 was $0.00.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | -$166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $294.00K derived: sum of 2 quarters · filed 2022-11-10 | $76.00K 10-Q · filed 2022-11-10 | $51.01M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-06-30 | $460.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $242.00K 10-Q · filed 2022-08-11 | $51.17M derived: sum of 3 quarters · filed 2022-08-11 | $91.58M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-03-31 | -$218.00K 10-Q · filed 2022-05-05 | $50.71M derived: sum of 2 quarters · filed 2022-05-05 | $91.13M derived: sum of 3 quarters · filed 2022-11-10 | $91.23M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-12-31 | $50.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $91.34M derived: sum of 2 quarters · filed 2022-11-10 | $91.45M derived: sum of 3 quarters · filed 2022-11-10 | $91.64M 10-K · filed 2022-02-24 | |
| 2021-09-30 | $40.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $40.52M derived: sum of 2 quarters · filed 2022-11-10 | $40.71M 10-Q · filed 2022-11-10 | $40.73M 10-Q · filed 2021-11-04 | $40.38M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $299.00K 10-Q · filed 2022-08-11 | -$38.00K derived: sum of 3 quarters · filed 2022-08-11 | -$205.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $195.00K 10-Q · filed 2022-05-05 | -$142.00K derived: sum of 2 quarters · filed 2022-05-05 | -$309.00K derived: sum of 3 quarters · filed 2022-05-05 | $112.74M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$504.00K derived: sum of 2 quarters · filed 2022-02-24 | $112.54M derived: sum of 3 quarters · filed 2022-02-24 | $112.55M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $112.88M derived: sum of 2 quarters · filed 2021-11-04 | $112.88M 10-Q · filed 2021-11-04 | $196.38M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $113.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $113.05M 10-Q · filed 2021-08-05 | $196.54M derived: sum of 3 quarters · filed 2021-08-05 | $195.27M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-06 | $83.50M derived: sum of 2 quarters · filed 2021-05-06 | $82.22M derived: sum of 3 quarters · filed 2021-05-06 | $90.14M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $83.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $82.22M derived: sum of 2 quarters · filed 2021-02-18 | $90.13M derived: sum of 3 quarters · filed 2021-02-18 | $174.99M 10-K · filed 2021-02-18 | |
| 2019-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $6.64M derived: sum of 2 quarters · filed 2020-11-05 | $91.49M 10-Q · filed 2020-11-05 | $91.49M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $7.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $92.77M 10-Q · filed 2020-08-05 | $92.77M derived: sum of 3 quarters · filed 2020-08-05 | ||
| 2019-03-31 | $84.85M 10-Q · filed 2020-05-11 | $84.85M derived: sum of 2 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-12-03 |